Advertisement

Topics

Latest "Seattle Genetics Inc." News Stories - Page: 4

19:37 EDT 24th March 2019 | BioPortfolio

Here are the most relevant search results for "Seattle Genetics Inc." found in our extensive news archives from over 250 global news sources.

More Information about Seattle Genetics Inc. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Seattle Genetics Inc. for you to read. Along with our medical data and news we also list Seattle Genetics Inc. Clinical Trials, which are updated daily. BioPortfolio also has a large database of Seattle Genetics Inc. Companies for you to search.

Showing "Seattle Genetics" News Articles 76–100 of 2,000+

Thursday 14th March 2019

Matinas BioPharma Announces Proposed Public Offering of Common Stock

Matinas BioPharma Holdings, Inc. (“Matinas BioPharma” or the “Company”) -- (NYSE AMER:MTNB), a clinical-stage biopharmaceutical company, today announced that it has commenced an underwritten public offering of its common stock. All of the shares to be sold in the offering are to be sold by Matinas BioPharma. In connection with the offering, Matinas ...


Harpoon Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update

Lead Tri-specific T cell Activating Construct (TriTAC) candidate, HPN424, continues to advance in a Phase 1 clinical trial for the treatment of prostate cancer Initial public offering, successfully completed in February, raised approximately $70.7 million in net cash proceeds Advanced HPN328, a DLL3 (Delta-like ...

National University System Partners With the Alliance for a Healthier Generation to Advance Social Emotional Learning Nationwide

Sanford Harmony, which is based on the vision of philanthropist T. Denny Sanford and offered through the National University System, will be made available to 42,000 schools and leaders of 3,500 after-school programs working with the Alliance for a Healthier Generation; The collaboration supports a broader movement to support healthy development of children SAN DIEGO (PRWEB) March 14, 2019 The Na...


ImmunogenX Initiates Phase 2 Trial for its Lead Therapeutic and Diagnostic Candidates Latiglutenase and CypCel

Both technologies address unmet needs for patients with celiac disease ImmunogenX is pleased to announce the initiation of a Phase 2 clinical trial (named Celiac Shield™), sponsored by the National Institutes of Health’s (NIH) National Center for Complementary and Integrative Health (NCCIH), to be conducted at the Mayo Clinic in Rochester, MN. The trial ...

GBM Patient & TOGETHER Day to Honor and Uplift Brain Cancer Patients on Friday, March 15th

In collaboration with regional and national partners, Seattle-based EndBrainCancer Initiative (EBCI) will host this inaugural afternoon event for brain cancer patients, caregivers, and families. SEATTLE (PRWEB) March 14, 2019 The EndBrainCancer Initiative is hosting its first ever GBM Patient & TOGETHER Day on Friday, March 15th at the Bellevue Club in Bellevue, Washington. GBM is short for ...

Genetics May Explain Why Birth Control Doesn't Always Work For Some Women

No form of birth control is 100 percent effective. Now, a new study provides an explanation for why a small number of women who use hormonal contraceptive methods still become pregnant, even if they use them correctly. A new study published in Obstetrics & Gynecology explains that some women have an uncommon genetic difference that makes hormonal contraception less effective for them. I...

SCC Soft Computer Welcomes SDS Pathology as a New Client

SCC Soft Computer (SCC) announced Specialist Diagnostic Services Pty Ltd (SDS Pathology), as a new client. SDS Pathology, the pathology division of Australian listed healthcare provider, Healius Limited, will be replacing their current system, Ultra (Triple G) with SCC’s Laboratory and Genetics Information Management Systems —including SCC’s...

Genomics Could Improve Treatment of Pancreatic Cancer

THURSDAY, March 14, 2019 -- It's one of the toughest cancers to beat. But new research suggests that identifying the genetics of pancreatic cancer in individual patients could boost survival for some. The five-year survival rate for pancreatic...

Raymond Schinazi Joins Precision BioSciences Board of Directors

Globally recognized leader in antiviral drug discovery and development Precision BioSciences (“Precision”), a genome editing company dedicated to improving life (DTIL) through its proprietary ARCUS genome editing platform, has appointed Raymond Schinazi, PhD, Hon DSc to its board of directors. Dr. Schinazi is the Frances Winship Walters Professor of ...

Co-Diagnostics, Inc. to Host 1st Semiannual Distributor Conference on March 26-28

Conference hosted at U.S. corporate headquarters to include training for distributors and end-users of Company’s diagnostic, research, and vector-control products Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be host...

AbCellera Signs Agreement with Global Health Foundation to Fight Infectious Disease

AbCellera today announced a two-year agreement with the Bill & Melinda Gates Foundation to help accelerate global health research. The funding, totaling $4.8 M, will support a series of scientific collaborations between AbCellera and Gates Foundation-funded scientists working on the prevention and treatment of high-priority infectious diseases. The ...

23andMe Offers Customers New Diabetes Risk Score

The personal genetics company has collaborated with artificial intelligence platform Lark Health to push diabetes prevention to customers of its Health & Ancestry service. Medscape Medical News

NexTech Brings AR to Healthcare & Cannabis Industries -- CFN Media

SEATTLE, March 14, 2019 (GLOBE NEWSWIRE) Read more...

Contextual Genomics Names Michael Ball as Chief Executive Officer

Contextual Genomics, a leading Canadian cancer genomics company, announced today that its Board of Directors has named Michael Ball as Chief Executive Officer. Mr. Ball was previously Global Vice President Commercial, Informatics, at Illumina, a market leader in the genomics industry. Prior to Illumina, Mr. Ball was the CEO of GenoLogics Life Sciences Soft...

Wednesday 13th March 2019

GBM Patient & TOGETHER Day to Honor and Uplift Brain Cancer Patients on Friday, March 15th

SEATTLE (PRWEB) March 14, 2019 The EndBrainCancer Initiative is hosting its first ever GBM Patient & TOGETHER Day on Friday, March 15th at the Bellevue Club in Bellevue, Washington. GBM is short for “Glioblastoma” which is the most common form of brain cancer, a stage 4 cancer. EBCI and...

Atossa Genetics Announces FDA Approval of Oral Endoxifen for "Expanded Access" as Post-Mastectomy Treatment for a U.S. Breast Cancer Patient

SEATTLE, March 14, 2019 (GLOBE NEWSWIRE) -- Atossa Genetics Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods to treat breast cancer and other breast conditions, today announced that...

[Review] Management of opioid use disorder in the USA: present status and future directions

Opioid use disorder is characterised by the persistent use of opioids despite the adverse consequences of its use. The disorder is associated with a range of mental and general medical comorbid disorders, and with increased mortality. Although genetics are important in opioid use disorder, younger age, male sex, and lower educational attainment level and income, increase the risk of opioid use dis...

BioForest Hotbed: The Fastest-Growing Life Science Market

A recent report by the U.S. Bureau of Labor Statistics and CBRE Research identified Seattle—which happens to be the BioSpace Bio Forest Hotbed—as the fastest-growing life science market in the top 10 from 2014 to 2017, with a greater than 17-percent growth.

Nimdzi to Conduct Statewide Medical Interpretation Project for California Department of Health Care Services (DHCS)

Nimdzi Insights LLC is launching a comprehensive project to assess current medical interpretation procedures in California, and to recommend ways to improve language services for the state’s Medicaid beneficiaries who speak little or no English. Mandated by the California State Legislature in August 2016, the project marks the initial implementa...

Tenaya Therapeutics Strengthens Leadership Team with Appointment of Two Biopharmaceutical Industry Veterans

–Company Expands Scientific Advisory Board with Addition of Experts in Cardiovascular Genetics, Gene Therapy and Molecular Biology– Tenaya Therapeutics, a biopharmaceutical company focused on developing potentially curative treatments for heart disease, today announced that it has strengthened its leadership team with the appointment of W...

Macklemore to Be Honored at 2019 MusiCares® Concert for Recovery Presented by Amazon Music

Benefit to Support MusiCares®' Addiction Recovery Programs Will Feature Joel McHale as Host at the Novo at L.A. Live on May 16 MusiCares®, an affiliated charity of the Recording Academy™, announced today that the 2019 MusiCares Concert For Recovery will honor multi-GRAMMY® winner Macklemore on Thursday, May 16 at The Novo at L.A. Liv...

Oklahoma, Wyoming and Arkansas Take Top Spots for Flu Activity

Walgreens Flu Index for Week Ending March 9, 2019 The Walgreens Flu Index™ is a weekly report developed to provide state- and market-specific information regarding flu activity, and ranks those states and markets experiencing the highest incidences of influenza across the country. This press release features multimedia. View the full release here: ht...

Keiretsu Forum Northwest Announces Record Attendance for March Angel Capital Expo; Pattern Computer Named the Winner of Its “Most Valued Company Award”

Shawn Iadonato, CEO of Kineta, Inc., was Presented with the “Entrepreneur of the Year” Award and Long-time Member Robin Foote Received “Most Active Investor” Award Keiretsu Forum announced today that the Northwest Region organization’s recent Angel Capital Expo event experienced record attendance. Out of 18 companies, Pattern Computer (www.pa...

Patient Panel Discusses “Supporting Patient Well-Being Beyond Outcomes” in March Episode of Openly Rare with Paul Kidwell Podcast

The March episode of Openly Rare with Paul Kidwell, a monthly podcast series dedicated to the discussion around rare diseases, features a recording of a panel discussion that took place during the annual International Rare Disease Day event that is sponsored by the Massachusetts Biotechnology Council. The panel, which was titled “Supporting Patient Well-...

Murrieta Genomics Inaugural Advisory Board Announced - Science, Technology, Business and Operations Leaders to Advise Incubator Companies

The Advisory Board will bring both industry specific and broader business experience to bear as genomic sequencing startups build their business models. MURRIETA, Calif. (PRWEB) March 13, 2019 Murrieta Genomics, the genomic sequencing business incubator, has released details of its Advisory Board. The Board will bring industry specific and broader business experience to bear as genomic sequencing...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks